Latest news
Marvel Biosciences Reports Positive Preclinical Data Demonstrating MB-204 Reverses Behavioural and Cognitive Deficits in a Mouse Model of Fragile X - The Manila TimesThe Manila Times · Wed, 05 Aug 2026 09:14:37 GMTSilexion Therapeutics Reports New Positive Preclinical - GlobeNewswireGlobeNewswire · Tue, 04 Aug 2026 13:15:00 GMT